Clover Biopharmaceuticals
Nicolas Burdin serves as Global Head of Research at Clover. Prior to Clover, Dr. Burdin spent 22 years in positions of increasing responsibility at Sanofi Pasteur where he contributed to the early development and translation of new vaccines against infectious diseases and to the strategic transformation of the company’s R&D technology and pipeline, including the introduction of its mRNA platform.
Dr. Burdin received his Ph.D. in immunology from Lyon 1 University.
This person is not in any offices
Clover Biopharmaceuticals
2 followers
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.